Supplementary Figure S5 from Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors

openalex(2023)

引用 0|浏览3
暂无评分
摘要
Supplementary Figure S5
更多
查看译文
关键词
anti-ceacam5–maytansinoid antibody–drug,sar408701,tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要